I agree with Canncan thought s/he writes it with great certainty, which I don't have. Here's my take. Nas could uplist now BUT they would be uplisting something that has a lot of gray to it. As I've written before, technically FDA says it's "illegal" to market CBD products as a food or a supplement. Say what? Yes, I heard a high level FDA person say that at a national conference. Then why hasn't FDA done anything about it? Well, it is FDA's job to remove unsafe products from the market. That includes products with manufacturing issues (e.g., spiked product, impurities, etc.) or if there has been overreach on labeling. So FDA HAS taken action against CBD companies that make claims ("we fight cancer cells, useful for arthritis), because these companies are making claims that are not supported and customers might believe them (hence unsafe). FDA has not hit CVSI because it does NOT make such claims AND there's no evidence for a safety issue. Secondly, technically, this is a schedule 1 substance (one of the most anti-intellectual decision in a long time, made by a bureaucrat with apparently little scientific understanding). So we're currently scheduled like cocaine. Thirdly, conservative financial institutions (e.g., Wells Fargo) won't even let their clients buy "pot stocks" (that may be changing, who knows). So with those 3 ditties, the conservative folk on Nasdaq are waiting for a change. With the Farm Bill done, the first 2 should be taken care of and after that, financial institutions will jump in.
All the best. MT
News 
Market Data 
Discover 
